keyword
Keywords Uterine adenosarcoma with stro...

Uterine adenosarcoma with stromal overgrowth

https://read.qxmd.com/read/25118497/adenosarcoma-of-the-uterine-body-initially-presenting-as-an-interstitial-small-tumor-of-the-uterus-a-case-report
#21
JOURNAL ARTICLE
H Miyata, N Tsuji, T Jimi, Y Butsuhara, K Terakawa, T Nagano
Adenosarcoma of the uterine body is a rare mixed tumor in which a benign epithelial component is mixed with a malignant stromal element. It has been considered that this tumor originates from the endometrium and its most common finding of imaging is a polypoid tumor occupying the uterine cavity. The authors herein present a case of 37-year-old female with a complaint of abnormal vaginal bleeding. At the first visit, transvaginal ultrasound and magnetic resonance imaging (MRI) showed a round mass with a diameter of one cm in the uterine wall...
2014: European Journal of Gynaecological Oncology
https://read.qxmd.com/read/24451763/uterine-sarcomas-histology-and-its-implications-on-therapy
#22
JOURNAL ARTICLE
Martee L Hensley
Uterine sarcomas are rare cancers, they comprise only 5% of all uterine malignancies. There are about 2,000 cases of uterine sarcoma diagnosed annually in the United States. Uterine sarcomas may be categorized as either favorable-risk, low-grade malignancies with a relatively good prognosis or as poor-risk, high-grade cancers that carry a high risk for tumor recurrence and disease progression. Expert histologic review is critical for appropriate diagnosis and management. Uterine sarcoma histologies considered to carry a more favorable prognosis include low-grade endometrial stromal sarcomas and adenosarcomas...
2012: American Society of Clinical Oncology Educational Book
https://read.qxmd.com/read/23283300/management-of-uterine-adenosarcomas-with-and-without-sarcomatous-overgrowth
#23
JOURNAL ARTICLE
Edward J Tanner, Thomas Toussaint, Mario M Leitao, Martee L Hensley, Robert A Soslow, Ginger J Gardner, Elizabeth L Jewell
OBJECTIVES: Uterine adenosarcomas (AS) are rare tumors composed of malignant stromal and benign epithelial components. We sought to evaluate the role of primary surgery, adjuvant treatments, and salvage therapies for patients with uterine adenosarcomas. METHODS: We identified all patients diagnosed with AS from 1990 to 2009 at our institution. Patient demographics, surgical procedures, sites of metastatic disease, and histologic features (e.g., presence of sarcomatous overgrowth, and heterologous elements) were collected...
April 2013: Gynecologic Oncology
https://read.qxmd.com/read/22953093/mullerian-adenosaroma-of-the-cervix-with-sarcomatous-overgrowth-and-heterologous-elements-presenting-as-a-recurrent-cervical-polyp
#24
JOURNAL ARTICLE
Slim Charfi, Rim Kallel, Hela Mnif, Sameh Ellouze, Mohamed Dhouib, Mohamed Guermazi, Abdelmajid Khabir, Tahya Sellami-Boudawara
Mullerian adenosarcoma of the cervix is a rare tumor composed of benign epithelial and malignant stromal components. Sarcomatous overgrowth and heterologous elements in cervical adenosarcoma are extremely infrequent. We report the case of a 26-year-old woman admitted at the gynaecology department for a painless mass protruding from her vagina. The initial pathological exam concluded to endocervical polyp. Six months later, the patient was readmitted with a recurrence of the polyp. The pathological exam demonstrated interlacing fascicles of elongated spindle cells with few mitotic activity and no glandular formation...
2012: Case Reports in Obstetrics and Gynecology
https://read.qxmd.com/read/22952480/mullerian-adenosarcoma-of-uterus-with-sarcomatous-overgrowth-and-heterologous-component-associated-with-stromal-deposit-in-omentum-a-case-report-and-review-of-the-literature
#25
JOURNAL ARTICLE
Anuradha Sinha, Jyoti Prakash Phukan, Sanjay Sengupta, Paulami Guha
Background. Mullerian adenosarcoma with sarcomatous overgrowth (MASO) is a very rare variant of uterine sarcomas first described by Clement et al. as early as 1974. The presence of heterologous sarcomatous components is associated with aggressive biological behavior. Case Presentation. This is a case report of a 62-year female (P(2 + 0)) presenting with postmenopausal vaginal bleeding. Her preoperative USG revealed subserosal fibroid with adherent omentum. She underwent abdominal hysterectomy with bilateral oophorectomy...
2012: Case Reports in Medicine
https://read.qxmd.com/read/21752716/staging-of-uterine-sarcomas
#26
REVIEW
Ka Yu Tse, Robin Crawford, Hextan Y S Ngan
Uterine sarcomas comprise leiomyosarcoma, endometrial stromal sarcoma, adenosarcoma, undifferentiated endometrial sarcoma, and their variants. Carcinosarcoma is historically classified as sarcoma, but it is now regarded as a metaplastic carcinoma. Uterine sarcomas are rare, and are traditionally staged in the same way as endometrial carcinoma. Because of their different clinical and biological behaviours, the International Federation of Gynecology and Obstetrics introduced a new staging system in 2009 for leiomyosarcoma, endometrial stromal sarcoma and adenosarcoma, and carcinosarcoma, respectively...
December 2011: Best Practice & Research. Clinical Obstetrics & Gynaecology
https://read.qxmd.com/read/21663687/cervical-mullerian-adenosarcoma-with-heterologous-sarcomatous-overgrowth-a-fourth-case-and-review-of-literature
#27
REVIEW
Tito Silvio Patrelli, Salvatore Gizzo, Stefania Di Gangi, Giorgia Guidi, Mario Rondinelli, Giovanni Battista Nardelli
BACKGROUND: Uterine sarcomas are relatively rare tumors that account for approximately 1-3% of female genital tract malignancies and between 4-9% of uterine cancers. Less than 8% of all cases are Mullerian adenosarcoma, a distinctive uterine neoplasm characterized by a benign, but occasionally atypical, epithelial and a malignant, usually low-grade, stromal component, both of which should be integral and neoplastic constituents of the tumor. Mullerian adenosarcoma with sarcomatous overgrowth (MASO) is a very aggressive variant, associated with post-operative recurrence, metastases, even when diagnosed in early stage...
June 11, 2011: BMC Cancer
https://read.qxmd.com/read/20613904/mullerian-adenosarcoma-heterologous-of-the-cervix-with-sarcomatous-overgrowth-a-case-report-with-review-of-literature
#28
JOURNAL ARTICLE
Rajan Duggal, Raje Nijhawan, Neelam Aggarwal, Pooja Sikka
Mullerian adenosarcoma is a rare biphasic malignant neoplasm of the cervix characterized by an admixture of benign epithelial elements and a malignant sarcomatous stromal component, which may be either homologous or heterologous. An aggressive variant of adenosarcoma, mullerian adenosarcoma with sarcomatous overgrowth (MASO) is extremely rare, with only two such cases being reported in the English literature to date. In this report we present a case of MASO of uterine cervix with heterologous elements in a 15-year-old unmarried girl presenting with foul smelling menstrual bleeding and passage of fleshy masses...
June 2010: Journal of Gynecologic Oncology
https://read.qxmd.com/read/20179434/mullerian-adenosarcoma-of-the-female-genital-tract
#29
REVIEW
W Glenn McCluggage
Mullerian adenosarcoma is an uncommon, but not rare, mixed tumor containing a neoplastic but benign or mildly atypical epithelial element and a sarcomatous, usually low-grade, stromal component. The most common site is the uterine corpus but adenosarcoma also occurs in the cervix and ovary and more rarely in the vagina, fallopian tube, arising from peritoneal surfaces, or outside the female genital tract, for example in the intestine. Most uterine cases have a polypoid gross appearance, sometimes resulting in the formation of multiple polyps...
March 2010: Advances in Anatomic Pathology
https://read.qxmd.com/read/19853898/uterine-sarcomas-a-review
#30
REVIEW
Emanuela D'Angelo, Jaime Prat
OBJECTIVE: Uterine sarcomas are rare tumors that account for 3% of uterine cancers. Their histopathologic classification was revised by the World Health Organization (WHO) in 2003. A new staging system has been recently designed by the International Federation of Gynecology and Obstetrics (FIGO). Currently, there is no consensus on risk factors for adverse outcome. This review summarizes the available clinicopathological data on uterine sarcomas classified by the WHO diagnostic criteria...
January 2010: Gynecologic Oncology
https://read.qxmd.com/read/19493521/mullerian-adenosarcoma-of-the-cervix-in-a-10-year-old-girl-case-report-and-review-of-the-literature
#31
REVIEW
Nathalie A Fleming, Laura Hopkins, Joseph de Nanassy, Mary Senterman, Amanda Y Black
UNLABELLED: Müllerian adenosarcoma is a rare neoplasm usually found in postmenopausal women. It usually presents as a polypoid mass within the endometrium. It is a biphasic tumor, composed of a benign epithelial component and a malignant stromal component. To date, this neoplasm has been reported in only 16 adolescent girls. We present a case of a 10-year-old girl who was diagnosed with müllerian adenosarcoma arising from the endocervix, the youngest female ever reported. CASE REPORT: A 10-year-old previously healthy girl presented to the Emergency Department at the Children's Hospital of Eastern Ontario with a painless mass protruding from her vagina...
August 2009: Journal of Pediatric and Adolescent Gynecology
https://read.qxmd.com/read/18941402/mullerian-adenosarcoma-a-clinicopathologic-and-immunohistochemical-study-of-55-cases-challenging-the-existence-of-adenofibroma
#32
JOURNAL ARTICLE
Alberto Gallardo, Jaime Prat
Mullerian adenosarcomas are rare mixed tumors of low malignant potential that occur mainly in the uterus and also in extrauterine locations. Microscopically, they may be difficult to distinguish from adenofibromas. In this clinicopathologic study of 55 adenosarcomas, the mean patient age was 50 years (range: 13 to 83 y). Thirty-seven tumors were of the uterine corpus, 11 of the cervix, 4 of the ovary, and 1 each of the fallopian tube, vagina, and Douglas peritoneum. Abdominal pain and vaginal bleeding were the usual complaints...
February 2009: American Journal of Surgical Pathology
https://read.qxmd.com/read/18469708/mullerian-adenosarcomas-an-immunophenotypic-analysis-of-35-cases
#33
COMPARATIVE STUDY
Robert A Soslow, Asya Ali, Esther Oliva
Mullerian adenosarcomas (MAs) are rare mixed mesenchymal and epithelial neoplasms that occur most commonly in the uterus. Although the epithelial component is typically benign, the mesenchymal component of most adenosarcomas morphologically resembles that observed in endometrial stromal tumors and is responsible for their clinical behavior. Thus, the differential diagnosis usually includes not only low-grade endometrial stromal tumors, but also adenofibroma, carcinosarcoma, and embryonal rhabdomyosarcoma especially in small samples...
July 2008: American Journal of Surgical Pathology
https://read.qxmd.com/read/17578809/m%C3%A3-llerian-adenosarcoma-with-sarcomatous-overgrowth-of-the-cervix-unusual-large-polypoid-mass
#34
JOURNAL ARTICLE
Nil Comunoğlu, Cem Comunoğlu, Nuray Başsüllü, Asli Somunkiran, Zerrin Calay
Müllerian adenosarcoma (MS) is a rare neoplasm of uterine cervix composed of benign epithelial and malignant stromal components. An aggressive variant of adenosarcoma, müllerian adenosarcoma with sarcomatous overgrowth (MASO) is extremely rare. The difference between MS and MASO is the pure high grade sarcoma features in MASO. In this report we present a MASO case, derived from uterine cervix of a 60 year-old-female patient presenting as a cervical polypoid mass, to our knowledge the second case of the English literature...
2007: Upsala Journal of Medical Sciences
https://read.qxmd.com/read/15582000/primary-vaginal-adenosarcoma-with-sarcomatous-overgrowth
#35
JOURNAL ARTICLE
Masafumi Toyoshima, Jun-ichi Akahira, Takuya Moriya, Seiichirou Hayakawa, Nobuo Yaegashi
BACKGROUND: Primary vaginal adenosarcomas are extremely rare, and typical adenosarcomas are of low malignancy. However, aggressive forms with sarcomatous overgrowth have been reported, those appear to have a poor prognosis. CASE: A 52-year-old woman who had undergone prior surgery for uterine leiomyoma and an ovarian cyst (total abdominal hysterectomy and left salpingo-oophorectomy) presented 10 years later with a rapidly enlarging tumor arising from the vaginal cuff...
December 2004: Gynecologic Oncology
https://read.qxmd.com/read/15571618/immunohistochemical-expression-of-cd10-antigen-in-uterine-adenosarcoma
#36
JOURNAL ARTICLE
F Amant, E Steenkiste, K Schurmans, L Verbist, V M Abeler, G Tulunay, E de Jonge, L Massuger, P Moerman, I Vergote
Uterine adenosarcoma (UAS) is microscopically characterized by a biphasic growth pattern. By definition, the epithelial component is benign, whereas the stromal component typically has the appearance of a low-grade sarcoma, usually an endometrial stromal sarcoma. CD10 acts by reducing cellular response to peptide hormones and is currently regarded as a specific marker for endometrial stromal tumors. In this international multicenter study, we further explored CD10 immunoreactivity in 30 UASs. We encountered CD10 positivity of the sarcomatous component in 18/20 (90%) of UASs, in five of eight (63%) of UASs with sarcomatous overgrowth as well as in both cases of recurrent UAS...
November 2004: International Journal of Gynecological Cancer
https://read.qxmd.com/read/15196864/immunohistochemical-determination-of-estrogen-and-progesterone-receptor-positivity-in-uterine-adenosarcoma
#37
MULTICENTER STUDY
Frederic Amant, Katrien Schurmans, Edwin Steenkiste, Lieve Verbist, Vera M Abeler, Gökhan Tulunay, Eric De Jonge, Leon Massuger, Philippe Moerman, Ignace Vergote
BACKGROUND: Given the paucity of data regarding hormone dependency, it was the purpose of this study to screen for the presence of estrogen and progesterone receptors in uterine adenosarcoma (UAS). METHODS: One hundred and five centers were asked to screen their files for uterine adenosarcomas. A immunohistochemical estrogen and progesterone receptor determination was performed. RESULTS: Twenty-eight primary UAS were stained, including one cervical adenosarcoma...
June 2004: Gynecologic Oncology
https://read.qxmd.com/read/12496702/evaluation-of-the-relationship-between-adenosarcoma-and-carcinosarcoma-and-a-hypothesis-of-the-histogenesis-of-uterine-sarcomas
#38
COMPARATIVE STUDY
Jeffrey D Seidman, Suman Chauhan
The terminology of uterine sarcomas is confusing and has been inconsistently applied. The relationships among the various types of uterine sarcomas are unknown. To elucidate the relationship between carcinosarcoma (malignant mullerian mixed tumor) and adenosarcoma, a series of 26 consecutive endometrial carcinosarcomas was evaluated for the presence of an adenosarcoma-like component. Four of 26 carcinosarcomas (15%) had an adenosarcoma-like component. The clinical and pathologic features of these tumors were otherwise similar to ordinary endometrial carcinosarcomas...
January 2003: International Journal of Gynecological Pathology
https://read.qxmd.com/read/11480728/m%C3%A3-llerian-adenosarcoma-of-the-uterus-report-of-a-case-with-imprint-cytology
#39
JOURNAL ARTICLE
N Takeshima, T Tabata, H Nishida, Y Arai, M Tsuzuku, Y Hirai, K Yamauchi, K Hasumi
BACKGROUND: Müllerian adenosarcoma is a rare morphologic variant of uterine sarcoma that, although well described histologically, is scarcely mentioned in the cytologic literature. CASE: A 75-year-old female was suspected of having atypical endometrial hyperplasia on an endometrial smear. However, subsequent imaging techniques revealed the presence of a bulky, polypoid mass filling the uterine cavity. On pathologic examination of the hysterectomy specimen, the polypoid tumor was diagnosed as mullerian adenosarcoma, homologous, with sarcomatous overgrowth, in which the sarcomatous component was compatible with high grade endometrial stromal sarcoma...
July 2001: Acta Cytologica
https://read.qxmd.com/read/10881074/m%C3%A3-llerian-adenosarcoma-of-the-uterus-with-sarcomatous-overgrowth-following-tamoxifen-treatment-for-breast-cancer
#40
JOURNAL ARTICLE
F M Carvalho, J P Carvalho, E V Motta, J Souen
Müllerian adenosarcoma with sarcomatous overgrowth presented by a 52-year-old female patient after adjuvant tamoxifen treatment for breast carcinoma is described. The diagnosis was made on histological basis after curettage and complementary total hysterectomy with bilateral salpingo-oophorectomy. The immunohistochemical study showed high expression of estrogen receptors in the epithelial component of the lesion and irregularly positive findings in the stroma. The proliferative activity evaluated by Ki-67 immunoexpression was higher in the stroma than the epithelium...
January 2000: Revista do Hospital Das Clínicas
keyword
keyword
121149
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.